360 results on '"Gartner S"'
Search Results
2. Host-Pathogen Diversity in a Wild System: Chondrilla juncea-Puccinia chondrillina
3. 731 CFTR-related metabolic syndrome (CRMS)/cystic fibrosis screen positive, inconclusive diagnosis (CFSPID): experience during 18 years.
4. Evolutionary Patterns of Modularity in the Linkage Systems of the Skull in Wrasses and Parrotfishes.
5. Calcareous Nannofossil Succession across the Cretaceous/Tertiary Boundary in East-Central Texas
6. Extensive sequence analysis of CFTR, SCNN1A, SCNN1B, SCNN1G and SERPINA1 suggests an oligogenic basis for cystic fibrosis-like phenotypes
7. Effects of dietary fatty acids on the reproductive success of the calanoid copepod Temora longicornis
8. Induced Sputum Cell Count and Cytokine Profile in Atopic and Non-Atopic Children With Asthma
9. DNase use in the daily care of cystic fibrosis: who benefits from it and to what extent? Results of a cohort study of 199 patients in 13 centres
10. Inconclusive diagnosis after a positive newborn bloodspot screening result for cystic fibrosis; clarification of the harmonised international definition
11. NEONATAL CYSTIC FIBROSIS SCREENING (1999- 2009) IN CATALUÑA, SPAIN: 438
12. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients
13. Host-pathogen diversity in a wild system: Chondrilla juncea–Puccinia chondrillina
14. Providing a microenvironment for the development of human CD34+ hematopoietic cells in SCID mice
15. Actinoplanic acids A and B as novel inhibitors of farnesyl-protein transferase
16. Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis
17. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort
18. P088 Ventilation inhomogeneity in patients with cystic fibrosis and pancreatic sufficiency and insufficiency
19. Lung transplantation in young infants with interstitial pneumonia
20. P019 Inconclusive Cystic Fibrosis Positive Neonatal Screening (CFSPID): clinical outcomes
21. WS06.1 Defining key outcomes to evaluate performance of newborn screening programmes for cystic fibrosis
22. Cell activation and astroglia stimulation
23. Extensive sequence analysis ofCFTR,SCNN1A,SCNN1B,SCNN1GandSERPINA1suggests an oligogenic basis for cystic fibrosis-like phenotypes
24. UPDATED SURVEY OF NEWBORN SCREENING FOR CYSTIC FIBROSIS IN EUROPE
25. Is palivizumab effective as a prophylaxis of respiratory syncytial virus infections in cystic fibrosis patients? A meta-analysis
26. WS20-1 An international survey to determine understanding of the designation of infants with an inconclusive diagnosis after newborn bloodspot screening for cystic fibrosis
27. WS07-6 Clinical characteristics of patients with normal spirometry - not as normal as it would seem!
28. 20 years experience with newborn screening for cystic fibrosis in Catalonia
29. Terminal Cretaceous Extinctions and the Arctic Spillover Model
30. Double-Factor Preimplantation Genetic Diagnosis: Preliminary Results
31. 425 The European cystic fibrosis patient registry in Spain: the long and winding road that leads to a National Registry Normal
32. 412 Spanish multicentre registry-based study on the phenotype of patients with cystic fibrosis carrying the V232D (c.695T>A) mutation
33. 219 Elevated prostaglandins urine levels is associated with disease severity in cystic fibrosis patients
34. 197 Bacteriophages and antibiotic resistance in cystic fibrosis
35. 24 Deep intronic mutations in cystic fibrosis patients detected by next generation sequencing
36. EPS2.6 Prevalence and characteristics of attention deficit hyperactivity disorder in patients with cystic fibrosis
37. WS02.1 Nasal nitric oxide levels as a useful additional tool to categorize patients with cystic fibrosis screen positive inconclusive diagnosis (CFSPID)
38. Bone Marrow Diffusion Measures Correlate with Dementia Severity in HIV Patients
39. Lead potentiation of endotoxin lethality in rats: Lack of effect of kininase inhibition
40. 2 Next Generation Sequencing genotyping project in Spanish cystic fibrosis patients with uncharacterized CFTR mutations
41. Continuous Parameterization of Leaf Area Index and Phenological Phases Within Deciduous Forests Based on Temperature Measurements
42. ePS06.7 Factors associated with failure to eradicate first or newly acquired Pseudomonas aeruginosa in patients with CF
43. Effects of dietary fatty acids on the reproductive success of the calanoid copepod Temora longicornis
44. The German national consensus on wound documentation and outcomes: Rationale, working programme and current status
45. A human body model initialization approach made real-time capable through heuristic constraints.
46. 14 Updated survey of newborn screening for cystic fibrosis
47. 20 Inconclusive diagnosis following newborn screening for cystic fibrosis (CF): clinical outcomes in 56 infants from three Spanish CF centres
48. Is neonatal screening a disease modifier?
49. 188 Association of lung function with adherence to inhaled antibiotic treatment in patients with cystic fibrosis (CF)
50. 174 Quantification of major urinary metabolite of PGE2 in cystic fibrosis (CF) patients: Correlation with parameters of disease severity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.